In order to leverage the market leading position in Thailand and expand to overseas markets, Osotspa will acquire 60% ownership in Osotspa VTA Joint Stock Company to carry out the trading business of
340.51 49.19 14.4 Finance costs 369.63 352.58 17.05 4.8 Income tax expense 233.25 217.75 15.50 7.1 Total expenses 2,325.81 2,155.04 170.77 7.9 2,116.88 1,839.91 276.97 15.1 Non-controlling Interests 36.09
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
-39.91 -30.16 -41.62 11.46 -27.53 Income tax (expense) revenue -1.56 0.46 4.70 -2.02 -439.13 -6.26 -133.19 -1.10 8.27 -9.37 -113.30 Actuarial gain (loss) - - - - - - - - 0.41 -0.41 -100 Net profit (loss
-24.31 3.46 -24.21 13.48 -55.45 -41.00 -65.92 24.92 -37.80 Income tax (expense) revenue 0.53 -1.56 0.39 2.09 -133.97 0.14 35.90 -0.57 8.66 -9.23 -106.58 Actuarial gain (loss) - - - - - - - - 0.41 -0.41
(expense) revenue 0.11 0.09 (1.52) (1.49) (1.63) (107.47) Profit (loss) for the year (7.52) (6.18) (14.88) (14.57) (7.36) (49.45) Other comprehensive income (loss) 0.00 0.00 0.00 0.00 0.00 0.00 Total
) Other incomes 5.54 3.47 2.07 59.7 Profit before interest and expense tax 82.87 104.18 (21.31) (20.5) Finance costs (35.08) (21.27) 13.81 64.9 Profit before expense tax 47.79 82.91 (35.12) (42.4) Expense
and expense tax 74.89 71.60 3.29 4.6 Finance costs (24.10) (22.24) 1.86 8.4 Profit before expense tax 50.79 49.36 1.43 2.9 Expense tax (11.84) (6.83) 5.01 73.4 Net profit 38.95 42.53 (3.58) (8.4) Gross